RxDoctor Payments Data

Amy Forren, DO

Family Medicine · Summerville, SCNPI 1073543153

Payments from drug & device makers

$910in general payments, 2019–2025

Across 62 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$177
  • GSK$135
  • Lilly USA, LLC$92
  • AstraZeneca$68
  • Sanofi-aventis U.S. LLC$66
  • Novo Nordisk$64
  • plus $308 from 16 others

What the payments were for

  • Food & beverage$89098%
  • Education$192%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$910 in reported general payments places this provider in the 55th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$256,163
Medicare patients
579
Services billed
3,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide88$117,579
MounjaroTirzepatide71$74,212
JardianceEmpagliflozin35$48,169
TrulicityDulaglutide26$31,122
EliquisApixaban21$29,000
LinzessLinaclotide17$25,030
FarxigaDapagliflozin Propanediol13$21,743
XareltoRivaroxaban13$20,927
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$18,729
JanuviaSitagliptin Phosphate13$11,460
Omeprazole286$4,093
Atorvastatin Calcium410$4,010
Rosuvastatin Calcium353$3,967
SynthroidLevothyroxine Sodium62$3,422
Levothyroxine Sodium258$2,483

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$64$117,57988 claims
Lilly USA, LLCMounjaro, Trulicity$92$105,33497 claims
Boehringer IngelheimJardiance$177$48,16935 claims
PfizerEliquis$13$29,00021 claims
AstraZenecaFarxiga$68$21,74313 claims
Johnson & JohnsonXarelto$16$20,92713 claims
GSKTrelegy Ellipta$135$18,72919 claims
MerckJanuvia$13$11,46013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Summerville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →